Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CEOs Are Buying and Selling Shares of These Companies

Page 1 of 3

Keeping tabs on insider trading behavior may be quite important for investors, because past research shows that insiders’ actions can offer an accurate reflection of the prospects for a company, industry or even a stock market in general. Intuitively, this makes perfect sense. After all, corporate insiders possess a broad set of skills and characteristics that could be used to describe the “value-oriented” type of investors.

Some of these skills and characteristics include: an extensive knowledge and understanding of their companies and industries; a tendency to employ the contrarian approach to investing; and a tendency to maintain a long term perspective. Hence, insider trading activity, especially insider buying, represents a strong source of information for long-term-oriented investors. As legendary investor Peter Lynch once said, corporate insiders may sell shares of their own companies for a variety of reasons such as estate planning or diversification benefits, but there is only one reason they buy – they think the price is going up. Insider Monkey identified a set of noteworthy insider transactions reported with the SEC on Wednesday, so this article will discuss notable insider trading recently witnessed at five U.S. publicly traded companies.

Through extensive research that covered the portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

insider trading insider buys

Chad McDermott / Shutterstock.com

CEO of Struggling Cruise Operator Buys Sizable Amount of Shares

The most influential corporate insider at Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH) purchased two separate blocks of shares at the end of August. Frank J. Del Rio, President and Chief Executive Officer, purchased a block of 55,623 shares on Wednesday at prices varying from $35.75 to $36.34 per share, lifting his direct ownership holding to 451,171 shares. Mr. Del Rio also snapped up a new stake of 27,875 shares on the same day at a weighted average cost of $35.90 per share, a stake owned directly by FJDR Family Trust.

The global cruise company, which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands, has lost 38% of its market capitalization since the beginning of the year. The aforementioned insider buying comes shortly after Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH) lowered its full-year earnings forecast to the range of $3.35-to-$3.45 per share from the previous guidance of $3.65-to-$3.85 per share. The revised earnings expectations reflect four main factors, which include “continued weak demand for our core North American consumer for European sailings at a time when half for our fleet is deployed in the region,” the impact of the weaker British pound following the United Kingdom’s decision to leave the European Union, among other things. Richard Barrera’s Roystone Capital Partners trimmed its position in Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH) by 57% during the June quarter to 846,700 shares.

Follow Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH)
Trade (NASDAQ:NCLH) Now!

The second page of the article discusses fresh insider buying witnessed at two companies, while the final page reveals noteworthy insider selling activity observed at two other companies.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!